136 related articles for article (PubMed ID: 2407872)
21. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
22. Diltiazem compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
Leary WP; van der Byl K
S Afr Med J; 1988 Jul; 74(1):13-5. PubMed ID: 3388151
[TBL] [Abstract][Full Text] [Related]
23. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
25. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension.
Chan P; Lin CN; Tomlinson B; Lin TH; Lee YS
Am J Hypertens; 1997 Jul; 10(7 Pt 1):743-9. PubMed ID: 9234828
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension.
Moser M; Lunn J; Materson BJ
Am J Cardiol; 1985 Dec; 56(16):101H-104H. PubMed ID: 4072939
[TBL] [Abstract][Full Text] [Related]
27. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.
Massie B; MacCarthy EP; Ramanathan KB; Weiss RJ; Anderson M; Eidelson BA; Labreche DG; Tubau JF; Ulep D; Bartels D
Ann Intern Med; 1987 Aug; 107(2):150-7. PubMed ID: 3300457
[TBL] [Abstract][Full Text] [Related]
28. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
Lacourcière Y; Lefebvre J; Poirier L; Archambault F; Arnott W
Am J Hypertens; 1994 Feb; 7(2):137-45. PubMed ID: 8179848
[TBL] [Abstract][Full Text] [Related]
29. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
Applegate W; Cohen JD; Wolfson P; Davis A; Green S
Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
[TBL] [Abstract][Full Text] [Related]
30. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
Wolfson P; Abernethy D; DiPette DJ; Zusman R
Am J Cardiol; 1988 Oct; 62(11):103G-108G. PubMed ID: 3051990
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
[TBL] [Abstract][Full Text] [Related]
32. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension.
Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D
Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639
[TBL] [Abstract][Full Text] [Related]
33. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
34. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study.
Neutel JM; Smith DH; Frishman WH
Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
36. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Multicenter Diuretic Cooperative Study Group.
Arch Intern Med; 1981 Mar; 141(4):482-6. PubMed ID: 7011237
[TBL] [Abstract][Full Text] [Related]
37. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
[TBL] [Abstract][Full Text] [Related]
38. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R
Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
[TBL] [Abstract][Full Text] [Related]
40. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
